This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback
Trial record 24 of 92 for:    "social work" | Recruiting, Not yet recruiting, Available Studies

Increasing MSM in the Continuum of Care in Kazakhstan

This study is not yet open for participant recruitment.
See Contacts and Locations
Verified February 2017 by Elwin Wu, Columbia University
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Elwin Wu, Columbia University
ClinicalTrials.gov Identifier:
NCT02786615
First received: May 26, 2016
Last updated: February 3, 2017
Last verified: February 2017
  Purpose
This study addresses the disproportionate representation of men who have sex with men (MSM) in the human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) pandemic in Kazakhstan, a country that has seen some of the largest growth in new HIV infections since the turn of the century. Using a stepped wedge trial across 4 cities in Kazakhstan, the proposed study will test a strategic and innovative social network-based intervention for MSM who use drugs in Kazakhstan as a strategy to increase their numbers in the HIV continuum of care as well as services that address issues that co-occur with HIV, including drug abuse, Hepatitis C Virus (HCV) infection, and other sexually transmitted infections.

Condition Intervention
HIV Substance-Related Disorders Behavioral: Peer Unity

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: No masking
Primary Purpose: Health Services Research
Official Title: Increasing Involvement of MSM in the Continuum of Care in Kazakhstan

Resource links provided by NLM:


Further study details as provided by Elwin Wu, Columbia University:

Primary Outcome Measures:
  • Number of participants who receive HIV testing [ Time Frame: Up to 36 months ]
  • Number of HIV-positive participants who initiate HIV-related medical care [ Time Frame: Up to 36 months ]
  • Number of HIV-positive participants who receive antiretroviral therapy (ART) [ Time Frame: Up to 36 months ]
  • Number of HIV-positive participants who achieve 90% ART adherence [ Time Frame: Up to 36 months ]
  • Number of HIV-positive participants on ART who achieve undetectable viral load [ Time Frame: Up to 36 months ]

Estimated Enrollment: 1000
Anticipated Study Start Date: October 1, 2017
Estimated Study Completion Date: May 2021
Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Peer Unity
Subjects assigned to this arm would receive a 4-session, group-delivered intervention focusing on peer/social network-based recruitment and referral program to receive HIV prevention and treatment services in the community.
Behavioral: Peer Unity
A 4-session, group-delivered intervention focusing on peer/social network-based recruitment and referral program to receive HIV prevention and treatment services in the community.
No Intervention: Pre-implementation
Subjects assigned to this arm would not receive the group-delivered intervention.

Detailed Description:
The intervention is designed to utilize MSM as experts and leverage social network processes to increase the number of MSM in Kazakhstan to be engaged in the HIV continuum of care. The unit of randomization will be a city, with the timing of roll-out of the social network-based intervention in each of the study's cities—Almaty, Astana, Pavlodar, and Shymkent—under experimental control. Receipt/delivery of an intervention to enrolled participants will depend on whether the city is in the intervention delivery phase or not. If a participant is in a city during a time period where the intervention is not being delivered then for that time period, the participant is in the control condition. If the participant is in a city during a time period where the intervention is being delivered then the participant (in fact, all participants in that city) will be considered assigned to the intervention group at that time. In theory, all participants will have the opportunity to experience and receive the intervention. Some participants will be enrolled after the intervention has been rolled out in the city in which they reside; thus, they will only experience the intervention condition and not the control condition.
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • be at least 18 years old;
  • identify as male; and
  • report oral or anal intercourse with another man in the past 12 months; and
  • report illicit use of substances in the past 12 months

Exclusion Criteria:

  • has a language or cognitive impairment that would prevent comprehension of study procedures, risks, and benefits (described in Russian during the informed consent process)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02786615

Contacts
Contact: Elwin Wu, PhD 212-851-2397 ew157@columbia.edu

Locations
United States, New York
Columbia University School of Social Work Not yet recruiting
New York, New York, United States, 10027
Contact: Elwin Wu, PhD    212-851-2397    ew157@columbia.edu   
Principal Investigator: Elwin Wu, PhD         
Kazakhstan
Global Health Research Center of Central Asia Not yet recruiting
Almaty, Kazakhstan
Contact: Assel Terlikbayeva, MD         
Sponsors and Collaborators
Columbia University
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Elwin Wu, PhD Columbia University
  More Information

Responsible Party: Elwin Wu, Associate Professor of Social Work, Columbia University
ClinicalTrials.gov Identifier: NCT02786615     History of Changes
Other Study ID Numbers: AAAQ7251
1R01DA040513-01A1 ( U.S. NIH Grant/Contract )
Study First Received: May 26, 2016
Last Updated: February 3, 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Elwin Wu, Columbia University:
men who have sex with men (MSM)

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on July 28, 2017